The Oncosearch | Oncotarget

Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development Review

Lingzhi Wang, Do Dang Khoa Phan, Jingwen Zhang, Pei-Shi Ong, Win Lwin Thuya, Ross Soo, Andrea Li-Ann Wong, Wei Peng Yong, Soo Chin Lee, Paul Chi-Lui Ho, Gautam Sethi, Boon Cher Goh

Published Mar 24, 2016 · Vol. 7, No. 28 · pp. 44790-44802

PD-L1 is an independent prognostic predictor in gastric cancer of Western patients Research Paper

Christine BÃ¶ger, Hans-Michael Behrens, Micaela Mathiak, Sandra KrÃ¼ger, Holger Kalthoff, Christoph RÃ¶cken

Published Mar 18, 2016 · Vol. 7, No. 17 · pp. 24269-24283

Emerging preclinical pharmacological targets for Parkinsonâ€™s disease Review

Sandeep Vasant More, Dong-Kug Choi

Published Mar 15, 2016 · Vol. 7, No. 20 · pp. 29835-29863

Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes Research Paper

Melissa M. NorstrÃ¶m, Emelie RÃ¥destad, Berit Sundberg, Jonas Mattsson, Lars Henningsohn, Victor Levitsky, Michael Uhlin

Published Mar 14, 2016 · Vol. 7, No. 17 · pp. 23581-23593

Age-related changes in the transcriptome of antibody-secreting cells Research Paper

Senthil Kannan, Noor Dawany, Raj Kurupati, Louise C. Showe, Hildegund C.J. Ertl

Published Mar 7, 2016 · Vol. 7, No. 12 · pp. 13340-13353

Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy Research Paper

Simon J. Dovedi, Amy L. Adlard, Yosuke Ota, Masashi Murata, Eiji Sugaru, Erina Koga-Yamakawa, Ken Eguchi, Yuko Hirose, Setsuko Yamamoto, Hiroki Umehara, Jamie Honeychurch, Eleanor J. Cheadle, Gareth Hughes, Philip J. Jewsbury, Robert W. Wilkinson, Ian J. Stratford, Timothy M. Illidge

Published Mar 5, 2016 · Vol. 7, No. 13 · pp. 17035-17046

Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer Research Paper

Eran Brauner, Viswanath Gunda, Pierre Vanden Borre, David Zurakowski, Yon Seon Kim, Kate Virginia Dennett, Salma Amin, Gordon James Freeman, Sareh Parangi

Published Mar 2, 2016 · Vol. 7, No. 13 · pp. 17194-17211

Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas Research Paper

Doris Helbig, Michaela Angelika Ihle, Katharina PÃ¼tz, Iliana Tantcheva-Poor, Cornelia Mauch, Reinhard BÃ¼ttner, Alexander Quaas

Published Mar 2, 2016 · Vol. 7, No. 16 · pp. 21763-21774

Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumors Research Paper

Ying Zhang, Hildegund C.J. Ertl

Published Mar 1, 2016 · Vol. 7, No. 17 · pp. 23282-23299

Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies Research Paper

Joanne Xiu, David Piccioni, Tiffany Juarez, Sandeep C. Pingle, Jethro Hu, Jeremy Rudnick, Karen Fink, David B. Spetzler, Todd Maney, Anatole Ghazalpour, Ryan Bender, Zoran Gatalica, Sandeep Reddy, Nader Sanai, Ahmed Idbaih, Michael Glantz, Santosh Kesari

Published Feb 25, 2016 · Vol. 7, No. 16 · pp. 21556-21569

Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma Research Paper

Guohe Lin, Yongcheng Liu, Shuhong Li, Yize Mao, Jun Wang, Zeyu Shuang, Jianlin Chen, Shengping Li

Published Feb 24, 2016 · Vol. 7, No. 32 · pp. 50963-50971

Transformation of the tumour microenvironment by a CD40 agonist antibody correlates with improved responses to PD-L1 blockade in a mouse orthotopic pancreatic tumour model Research Paper

Nadia M. Luheshi, Jane Coates-Ulrichsen, James Harper, Stefanie Mullins, Michal G. Sulikowski, Philip Martin, Lee Brown, Arthur Lewis, Gareth Davies, Michelle Morrow, Robert W. Wilkinson

Published Feb 23, 2016 · Vol. 7, No. 14 · pp. 18508-18520

The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response Review

Min Luo, Liwu Fu

Published Feb 23, 2016 · Vol. 7, No. 20 · pp. 29794-29803

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis Research Paper

Francesco Passiglia, Giuseppe Bronte, Viviana Bazan, Clara Natoli, Sergio Rizzo, Antonio Galvano, Angela ListÃ¬, Giuseppe Cicero, Christian Rolfo, Daniele Santini, Antonio Russo

Published Feb 22, 2016 · Vol. 7, No. 15 · pp. 19738-19747

Keywords: PD-L1, predictive biomarker, immunotherapy, anti-PD1/PD-L1 MoAbs, NSCLC

CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity Research Paper

Melanie Straub, Enken Drecoll, Nicole Pfarr, Wilko Weichert, Rupert Langer, Alexander Hapfelmeier, Carolin GÃ¶tz, Klaus-Dietrich Wolff, Andreas Kolk, Katja Specht

Published Feb 22, 2016 · Vol. 7, No. 11 · pp. 12024-12034

The prevalence and clinicopathological features of programmed death-ligand 1 (PD-L1) expression: a pooled analysis of literatures Research Paper

Ziying Lin, Yutong Xu, Yaxiong Zhang, Qihua He, Jianrong Zhang, Jianxing He, Wenhua Liang

Published Feb 22, 2016 · Vol. 7, No. 12 · pp. 15033-15046

IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas Research Paper

Peter S. Kim, Anna R. Kwilas, Wenxin Xu, Sarah Alter, Emily K. Jeng, Hing C. Wong, Jeffrey Schlom, James W. Hodge

Published Feb 18, 2016 · Vol. 7, No. 13 · pp. 16130-16145

PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma Research Paper

Chan-Young Ock, Sehui Kim, Bhumsuk Keam, Miso Kim, Tae Min Kim, Jin-Ho Kim, Yoon Kyung Jeon, Ju-Seog Lee, Seong Keun Kwon, Hun J. Hah, Tack-Kyun Kwon, Dong-Wan Kim, Hong-Gyun Wu, Myung-Whun Sung, Dae Seog Heo

Published Feb 17, 2016 · Vol. 7, No. 13 · pp. 15901-15914

Repulsive guidance molecule B inhibits metastasis and is associated with decreased mortality in non-small cell lung cancer Research Paper

Jin Li, Lin Ye, Xiaoshun Shi, Jingyi Chen, Fenglan Feng, Yaoqi Chen, Yiren Xiao, Jianfei Shen, Peng Li, Wen G. Jiang, Jianxing He

Published Feb 17, 2016 · Vol. 7, No. 13 · pp. 15678-15689

NFE2L2 variations reduce antioxidant response in patients with Parkinson disease Research Paper

YaXing Gui, LiShan Zhang, Wen Lv, WenMing Zhang, JinJia Zhao, XingYue Hu

Published Feb 12, 2016 · Vol. 7, No. 10 · pp. 10756-10764

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development Review

PD-L1 is an independent prognostic predictor in gastric cancer of Western patients Research Paper

Emerging preclinical pharmacological targets for Parkinsonâ€™s disease Review

Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes Research Paper

Age-related changes in the transcriptome of antibody-secreting cells Research Paper

Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy Research Paper

Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer Research Paper

Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas Research Paper

Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumors Research Paper

Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies Research Paper

Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma Research Paper

Transformation of the tumour microenvironment by a CD40 agonist antibody correlates with improved responses to PD-L1 blockade in a mouse orthotopic pancreatic tumour model Research Paper

The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response Review

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis Research Paper

CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity Research Paper

The prevalence and clinicopathological features of programmed death-ligand 1 (PD-L1) expression: a pooled analysis of literatures Research Paper

IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas Research Paper

PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma Research Paper

Repulsive guidance molecule B inhibits metastasis and is associated with decreased mortality in non-small cell lung cancer Research Paper

NFE2L2 variations reduce antioxidant response in patients with Parkinson disease Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development Review

PD-L1 is an independent prognostic predictor in gastric cancer of Western patients Research Paper

Emerging preclinical pharmacological targets for Parkinsonâ€™s disease Review

Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes Research Paper

Age-related changes in the transcriptome of antibody-secreting cells Research Paper

Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy Research Paper

Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer Research Paper

Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas Research Paper

Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumors Research Paper

Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies Research Paper

Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma Research Paper

Transformation of the tumour microenvironment by a CD40 agonist antibody correlates with improved responses to PD-L1 blockade in a mouse orthotopic pancreatic tumour model Research Paper

The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response Review

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis Research Paper

CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity Research Paper

The prevalence and clinicopathological features of programmed death-ligand 1 (PD-L1) expression: a pooled analysis of literatures Research Paper

IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas Research Paper

PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma Research Paper

Repulsive guidance molecule B inhibits metastasis and is associated with decreased mortality in non-small cell lung cancer Research Paper

NFE2L2 variations reduce antioxidant response in patients with Parkinson disease Research Paper